PharVision Advisers’s Everforth Inc EFOR Stock Holding History

PharVision Advisers’s Portfolio EFOR Stock Details EFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,411	Closed	-$357K	–	137
2025 Q4	$357K	Buy	+7,411	New	+$342K	0.18%	181

Other funds holding EFOR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

PharVision Advisers's EFOR Position: Q1 2026 in Review

PharVision Advisers sold out of Everforth Inc (EFOR) in Q1 2026, closing a stake of 7,411 shares — an estimated $357K sold.

PharVision Advisers first reported a position in EFOR in Q4 2025 and held it in 1 quarter. The position peaked at $357K in Q4 2025. 249 funds tracked by Wall St. Rank hold EFOR as of Q1 2026.

PharVision Advisers reported no remaining Everforth Inc position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 7,411 Everforth Inc shares in Q1 2026, an estimated $357K.
PharVision Advisers first reported a position in Everforth Inc in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Everforth Inc position peaked at $357K in Q4 2025.
249 funds tracked by Wall St. Rank held Everforth Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.